✦ LIBER ✦

Optimal Duration of Cardiac Monitoring in Metastatic HER2-positive Breast Cancer Patients Receiving Trastuzumab

✍ Scribed by Chiu, K.; Dubey, S.; Bull, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in HER2-positive metast

✍ Kaplan, Muhammet Ali; Ertugrul, Hamza; Firat, Ugur; Kucukoner, Mehmet; İnal, Ali 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 204 KB

Extended survival in women receiving tra

✍ D.N. Church; Modgil; S. Guglani; A. Bahl; K. Hopkins; J.P. Braybrooke; C.G.A. Pr 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Characteristics of patients with brain m

✍ H.J. Stemmler; S. Kahlert; W. Siekiera; M. Untch; B. Heinrich; V. Heinemann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Cardiac Toxicity Monitoring for HER2-pos

✍ Gujral, D.M.; Lloyd, G.; Bhattacharyya, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Population pharmacokinetics of trastuzum

✍ Rene Bruno; Carla B. Washington; Jian-Feng Lu; Grazyna Lieberman; Ludger Banken; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 354 KB

Effect of Cardiac Dysfunction on Treatme

✍ Debu Tripathy; Andrew Seidman; Deborah Keefe; Clifford Hudis; Virginia Paton; Gr 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB